Bookmark

Add to MyYahoo RSS

DePuy Orthopaedics News

News on DePuy Orthopaedics (Ticker: JNJ) continually updated from thousands of sources around the net.

5 hrs ago | Colorado Springs Independent

The poison in baby products

Look at the big change won earlier this year when the labels on Johnson's Baby Shampoo announced: "Improved Formula." This popular Johnson & Johnson baby product has long been advertised with the comforting slogan, "No More Tears," for the shampoo's ingredients don't sting a tiny tot's eyes.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Sep 15, 2014

Reuters

Lawyer grills DePuy executive over safety studies for Pinnacle hips

An executive at Johnson & Johnson's DePuy Orthopaedics Inc unit on Monday defended the company's assessment of safety risks associated with metal-on-metal Pinnacle hip implants in a Dallas court from a lawyer who said the company had neglected to perform critical safety testing. Pamela Plouhar, the worldwide vice president of clinical research at DePuy, was grilled by a lawyer for plaintiff Kathy Herlihy-Paoli during the first trial among more than 6,000 lawsuits over the Pinnacle hips that have been consolidated in Dallas federal court.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Medical Equipment, Healthcare Industry, Food and Drug Administration

Forbes.com

One Put, One Call Option To Know About for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the January 2017 expiration for JNJ.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Fri Sep 12, 2014

PR-inside.com

Taiwan baby products market: Johnson & Johnson and BA1 4bchen the...

These include Johnson & Johnson, BA1 4bchen, Sebamed, Chicco and Pigeon, which together accounted for 71% of total sales in 2012. International brands have a higher acceptance amongst parents.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Sep 10, 2014

WHAS11

Jewish Hospital awarded grant to fight childhood obesity

LOUISVILLE, Ky. Jewish Hospital has received a major grant to help fight childhood obesity.

Comment?

Related Topix: Louisville, KY, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Motley Fool

A Top Dividend Stock for Your Portfolio: Johnson & Johnson

Dividend stocks are an essential ingredient to a well-balanced portfolio. Even so, it's important to bear in mind that not all dividend stocks are created equal.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Tue Sep 09, 2014

PR-inside.com

Germany baby products market: Johnson & Johnson the leading industry...

It was followed by NestlA© Deutschland with a 15% value share, Procter & Gamble Germany & Co Operations with an 8% value share and Hipp with a 4% value share. All of the top four companies offer a wide range of attractive baby and child-specific products with competitive prices.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

TheStreet.com

Bristol-Myers Needs a Healthy Growth Shot to Justify Its Valuation

With shares around $51 and down nearly 4% on the year to date, Bristol-Myers investors could have done much better elsewhere -- Johnson & Johnson , for instance. Johnson & Johnson stock has posted gains of 16% and beating the health care sector's 11% gain, according to Morningstar.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Johnson & Johnson, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Medical Equipment, Hospital Administration, St Peters Health Care Services

Mon Sep 08, 2014

Forbes.com

Interesting January 2015 Stock Options for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson . So this week we highlight one interesting put contract, and one interesting call contract, from the January 2015 expiration for JNJ.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Sep 04, 2014

The Motley Fool

Bristol-Myers Squibb's Eliquis Takes Aim at Johnson & Johnson

Eliquis, a factor Xa inhibitor used by doctors to prevent blood clots in heart disease patients and patients following orthopedic surgery, is quickly gaining ground on Johnson & Johnson's Xarelto, a billion-dollar blockbuster the company rolled out in 2011. Since Eliquis sales are jumping and pose a potential threat to Johnson & Johnson's market share, let's take a closer look.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Sep 03, 2014

Wall Street Journal

Johnson & Johnson to Quicken Development of Ebola Vaccine

Johnson & Johnson said Thursday it is accelerating the development of a vaccine regimen against Ebola, in an effort to help curb the virus that has overwhelmed West Africa. The regimen consists of two vaccine components from Johnson & Johnson's Crucell NV and Denmark-based biotech company Bavarian Nordic, both of which are developing vaccines against filoviruses, including Ebola.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Crucell NV, Medical Equipment, Hospital Administration, St Peters Health Care Services

The Washington Post

J&J Unit Ran - Amok' Marketing Pinnacle Hips, Jury Is Told

Johnson & Johnson's bid to convince doctors the metal-on-metal version of its Pinnacle hip implants were safe amounted to "marketing run amok," a lawyer told jurors in the first case over the devices to go to trial.

Comment?

Related Topix: Medicine, Medical Equipment, Healthcare Industry, Metal, Business News

Tue Sep 02, 2014

Adweek

Moms Shopping for Baby Gear Are Swayed by Online Recommendations

A new survey from BabyCenter finds that nearly two-thirds of upper-income millennial moms are influenced by online recommendations when shopping for baby gear.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Bloomberg

J&J's Pinnacle Hips Face First Trial on Poisoned Patients

Johnson & Johnson , which set aside $2.5 billion last year to resolve claims that 8,000 of its artificial hips were defective, faces a new round of lawsuits over another line of hip implants blamed for poisoning patients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics, Medical Equipment

Thu Aug 28, 2014

Wall Street Journal

J&J Seeks Buyer for Cordis Unit

Johnson & Johnson plans to seek a buyer for a business that makes medical devices including stents and catheters, said people familiar with the matter, the latest effort by the health care giant to pare its wide-ranging portfolio.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

TheStreet.com

Why Johnson & Johnson (JNJ) Stock Is Declining Today

The FDA announced that the recall was of the most serious Class 1 category as the device can cause serious injury or death.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Reuters

FDA says Johnson & Johnson recalls some jaw implants

Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Food and Drug Administration, Medical Equipment, Hospital Administration, St Peters Health Care Services

CBC News

Jaw implants recalled

Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw, following more than a dozen cases of injury.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

TheStreet.com

Frustrating Boston Scientific Is Not What the Investor Ordered

The shares peaked in January at $14.08 and have grossly underperformed its peers ever since.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

Thu Aug 21, 2014

BioSpace

ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Announces Signing Of Rights Agreement With

The agreement provides Janssen with a future right to evaluate a transaction related to the VC-01 combination product that ViaCyte is developing for type 1 diabetes.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, Medical Equipment, Hospital Administration, St Peters Health Care Services

•••
•••
•••
•••

Woodbridge Jobs

•••
•••
•••
•••